Pinthus JH - Search Results

1

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

Zareba P, Duivenvoorden W, Leong DP, Pinthus JH. Zareba P, et al. Among authors: pinthus jh. Ther Adv Urol. 2016 Apr;8(2):118-29. doi: 10.1177/1756287215617872. Epub 2015 Nov 30. Ther Adv Urol. 2016. PMID: 27034724 Free PMC article. Review.

2

Cardiovascular effects of androgen depletion and replacement therapy.

Pinthus JH, Trachtenberg J, Klotz L. Pinthus JH, et al. Urology. 2006 Jun;67(6):1126-32. doi: 10.1016/j.urology.2006.01.076. Urology. 2006. PMID: 16765164 Review. No abstract available.

3

Adiponectin inhibits oxidative stress in human prostate carcinoma cells.

Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A, Pinthus JH. Lu JP, et al. Among authors: pinthus jh. Prostate Cancer Prostatic Dis. 2012 Mar;15(1):28-35. doi: 10.1038/pcan.2011.53. Epub 2012 Jan 17. Prostate Cancer Prostatic Dis. 2012. PMID: 22249290

4

Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo.

Duivenvoorden WC, Beatty LK, Lhotak S, Hill B, Mak I, Paulin G, Gallino D, Popovic S, Austin RC, Pinthus JH. Duivenvoorden WC, et al. Among authors: pinthus jh. Br J Cancer. 2013 Feb 5;108(2):327-33. doi: 10.1038/bjc.2012.574. Epub 2013 Jan 15. Br J Cancer. 2013. PMID: 23322200 Free PMC article.

5

Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.

Paschos A, Pandya R, Duivenvoorden WC, Pinthus JH. Paschos A, et al. Among authors: pinthus jh. Prostate Cancer Prostatic Dis. 2013 Sep;16(3):217-25. doi: 10.1038/pcan.2013.13. Epub 2013 May 14. Prostate Cancer Prostatic Dis. 2013. PMID: 23670256 Review.

6

Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.

Kleinmann N, Duivenvoorden WC, Hopmans SN, Beatty LK, Qiao S, Gallino D, Lhotak S, Daya D, Paschos A, Austin RC, Pinthus JH. Kleinmann N, et al. Among authors: pinthus jh. Clin Exp Metastasis. 2014 Feb;31(2):169-83. doi: 10.1007/s10585-013-9618-1. Epub 2013 Oct 5. Clin Exp Metastasis. 2014. PMID: 24096711

7

Endoplasmic reticulum protein ERp46 in renal cell carcinoma.

Duivenvoorden WC, Paschos A, Hopmans SN, Austin RC, Pinthus JH. Duivenvoorden WC, et al. Among authors: pinthus jh. PLoS One. 2014 Mar 3;9(3):e90389. doi: 10.1371/journal.pone.0090389. eCollection 2014. PLoS One. 2014. PMID: 24594673 Free PMC article.

8

Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.

Zareba P, Patterson L, Pandya R, Margel D, Hotte SJ, Mukherjee SD, Elavathil L, Daya D, Shayegan B, Pinthus JH. Zareba P, et al. Among authors: pinthus jh. Urol Oncol. 2014 Oct;32(7):975-80. doi: 10.1016/j.urolonc.2014.03.025. Epub 2014 Jul 11. Urol Oncol. 2014. PMID: 25027682

9

GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.

Hopmans SN, Duivenvoorden WC, Werstuck GH, Klotz L, Pinthus JH. Hopmans SN, et al. Among authors: pinthus jh. Urol Oncol. 2014 Nov;32(8):1126-34. doi: 10.1016/j.urolonc.2014.06.018. Epub 2014 Sep 18. Urol Oncol. 2014. PMID: 25242517

10

Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?

Pinthus JH. Pinthus JH. J Urol. 2015 Jun;193(6):1882-3. doi: 10.1016/j.juro.2015.03.070. Epub 2015 Mar 17. J Urol. 2015. PMID: 25794833 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page